Where is Insilico headquartered?

Insilico is located in Pak Shek Kok, other.

Who invested in Insilico ?

Insilico has 13 investors including Geekdom Fund And Geekdom Fund.

When was the last funding round for Insilico ?

Insilico closed its lastf unding roundon Jul 19, 2017 from a Convertible Note round.

Company Information
Company Timeline (Coming Soon)

insilico.com

Insilico

Insilico is a Hong Kong-based biotechnology firm that offers solutions such as AI-powered drug discovery and clinical trial prediction for the life sciences industry.

Business Model:

Revenue: $11.2M

Employees: 51-200

Geographic Data

Address: 307A, 1 Science Park East Avenue

City: Pak Shek Kok

State: other

Zip:

Country: HK

Financial Info

Stage:

series d

Raised Last:

$60M

Raised Total:

$366M

Social

Facebook

Twitter

Crunchbase

Metrics

1,933,335Website Global Rank

11,042Website Monthly Traffic

Twitter Followers

Description

Insilico is a Hong Kong-based biotechnology firm that offers solutions such as AI-powered drug discovery and clinical trial prediction for the life sciences industry.

Contact Phone:

Contact Email:

Investments

Announced Date	Company	Transaction	Money Raised

Funding Rounds

Announced Date	Transaction	Number of Investors	Money Raised	Lead Investors
6/2021	Series C		$0	B Capital Group Warburg Pincus Baidu Ventures Bold Capital Partners CPE Deerfield Eight Roads Ventures Formic Ventures Lake Bleu Capital Lilly Asia Ventures Maison Capital Mirae Asset Capital OrbiMed Pavilion Capital President International Development Corporation Qiming Venture Partners Sequoia Capital China Sinovation Ventures B Capital Group Warburg Pincus Baidu Ventures Bold Capital Partners CPE Deerfield Eight Roads Ventures Formic Ventures Lake Bleu Capital Lilly Asia Ventures Maison Capital Mirae Asset Capital OrbiMed Pavilion Capital President International Development Corporation Qiming Venture Partners Sequoia Capital China Sinovation Ventures
4/2014	Seed Round	1	$300k	Deep Knowledge Group Deep Knowledge Group
9/2019	Series B	11	$37M	Sinovation Ventures Qiming Venture Partners Pavilion Capital Longevity Vision Fund Lilly Asia Ventures Harmonix Fund F-Prime Capital Formic Ventures Eight Roads Ventures Bold Capital Partners Qiming Venture Partners
2/2017	Series A		$0	A-Level Capital Jim Mellon A-Level Capital Jim Mellon
8/2022	Series D	9	$35M	Wilson Sonsini Goodrich &a; Rosati Warburg Pincus Qiming Venture Partners Prosperity7 Ventures Pavilion Capital Deepfield Bold Capital Partners BHR Partners B Capital Group Prosperity7 Ventures Aramco Ventures B Capital Group Warburg Pincus BHR Partners Qiming Venture Partners Deerfield Pavilion Capital BOLD Capital Partners Wilson Sonsini Goodrich & Rosati
6/2018	Series A	4	$6M	WuXi AppTec Pavilion Capital Juvenescence Bold Capital Partners WuXi AppTec
9/2019	Series B	11	$37M	Qiming Venture Partners Sinovation Ventures Pavilion Capital Longevity Vision Fund Lilly Asia Ventures Harmonix Fund F-Prime Capital Formic Ventures Eight Roads Ventures Bold Capital Partners Qiming Venture Partners Sinovation Ventures Pavilion Capital Longevity Vision Fund Lilly Asia Ventures Harmonix Fund F-Prime Capital Formic Ventures Eight Roads Ventures Bold Capital Partners
1/2022	Corporate Round		-	Fosun Pharma Fosun Pharma
6/2022	Series D		$0	Alex Zhavoronkov B Capital Group BHR Partners Bold Capital Partners Deerfield Pavilion Capital Qiming Venture Partners Warburg Pincus Alex Zhavoronkov B Capital Group BHR Partners Bold Capital Partners Deerfield Pavilion Capital Qiming Venture Partners Warburg Pincus
7/2017	Series A		$4M
11/2014	Convertible Note	1	$1.2M	Deep Knowledge Group Deep Knowledge Group
5/2018	Venture Round		$6M	Pavilion Capital Bold Capital Partners WuXi AppTec Juvenescence Limited
8/2022	Series D		$35M
6/2022	Series D	8	$60M	BHR Partners Warburg Pincus B Capital Group Qiming Venture Partners BOLD Capital Partners Pavilion Capital Alex Zhavoronkov B Capital Group BHR Partners Bold Capital Partners Deerfield Pavilion Capital Qiming Venture Partners Warburg Pincus
6/2021	Series C	18	$255M	Warburg Pincus Qiming Venture Partners Pavilion Capital Eight Roads Ventures Lilly Asia Ventures Sinovation Ventures BOLD Capital Partners Formic Ventures Baidu Ventures CPE OrbiMed Mirae Asset Capital B Capital Group Deerfield Management Maison Capital Lake Bleu Capital Sequoia Capital China Sage Partners B Capital Group Warburg Pincus
1/2022	Corporate Round	1	-	Fosun Pharma Fosun Pharma
2/2017	Series A	2	$2.8M

Acquisitions

Announced Date	Name	Price

Employee Demographics

Employee Departments

Employee States

Similar Companies

Uniview Singapore VEID	Revenue: 0 - 100000 Employees: Industry: Software	Details
Konkuk University Medical Center	Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education	Details
Daemon Technologies	Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain	Details
Ace International Trade	Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial	Details
An Hòa Communications	Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising	Details